Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Veeva Systems Inc.

Veeva Systems Inc. has announced its participation in the Raymond James 2025 TMT and Consumer Conference, set for December 8, 2025. CFO Brian Van W...

Veeva Systems to present at Raymond James Conference. Market reacts to Samsara's price increase, historically linked to Veeva.

Veeva Systems Inc has experienced a price increase of 0.4% since Friday. A social media post made during trading hours 12 hours ago characterized a...

Veeva Systems sees gains after social media post calls recent sell-off unjustified. Market reacts to weaker ISM Manufacturing PMI data.

Veeva Systems Inc is experiencing an increase in its stock price, aligning with broader market trends, particularly within the Health Care Technolo...

Veeva Systems' stock rises amid Health Care Tech trends. Wells Fargo's Overweight rating adjusted price target to 333, signaling a favorable outlook.

Veeva Systems Inc. has announced an expansion of its partnership with Roche Pharmaceuticals, which will implement Veeva Vault CRM across its global...

Veeva expands partnership with Roche for global CRM. AI integration aims to enhance customer engagement and insights for healthcare professionals.

Earnings call commentary overshadows the software company's fiscal-year guidance boost.

Veeva Systems Earnings Beat Expectations. Why the Stock Is Tumbling.

Veeva Systems Inc. reported its third-quarter fiscal 2026 results, revealing revenue of $811.2 million, surpassing analyst expectations and reflect...

Veeva's Q3 results beat expectations with $811.2M revenue. Analysts express confusion over share decline despite strong earnings and revised guidance.

Veeva Systems Inc. announced the resignation of Chief Accounting Officer Kristine Diamond, effective December 11, 2025. Diamond informed the compan...

Veeva's Chief Accounting Officer resigns, CFO to fill role. Q3 FY2026 earnings due Nov 20, with strong revenue growth expected.

Veeva Systems Inc is currently experiencing a price decline, moving in tandem with the broader market, which is also trending lower. The company is...

Veeva Systems faces price decline amid cautious market. Q3 FY2026 earnings estimate drops to $1.71, despite revenue rise to $792.3M.

Veeva Systems Inc is experiencing a significant decline in its stock price, dropping in tandem with the broader market and specifically the Health...

Veeva Systems stock declines amid cautious market sentiment. Q3 earnings on November 20 show EPS estimate down, but revenue expectations rise.

Veeva Systems Inc is currently experiencing a price decline of 3.0%, coinciding with a broader downturn in the Health Care Technology sector. Analy...

Veeva's price decline aligns with the Health Care Technology sector's downturn. Analysts remain optimistic, though mixed opinions suggest cautious...

Veeva Systems Inc is experiencing an upward movement, in line with the broader trend in the Health Care Technology sector. The company has recently...

Veeva Systems partners with OpenEvidence to enhance patient access to trials. This AI initiative targets unmet medical needs, improving drug discov...

Veeva Systems Inc announced plans to launch AI agents across its applications, beginning with commercial use in December 2025. The rollout will enc...

Veeva Systems aims to boost life sciences innovation with AI agents by December 2025. This strategic move may positively influence market performance.

China Merchants Securities has initiated coverage on Veeva Systems (NYSE: VEEV) with a Buy rating and set a price target of 351.00. This announceme...

China Merchants Securities rates Veeva Systems a Buy, targeting $351. This reflects confidence in Veeva's growth potential amid current market cond...

Veeva Systems Inc has been upgraded to a "Buy" rating from "Hold" by TD Cowen, with the price target raised to 380.00 per share from a previous 297...